» Articles » PMID: 30821074

A Functional Interaction Between Hippo-YAP Signalling and SREBPs Mediates Hepatic Steatosis in Diabetic Mice

Overview
Journal J Cell Mol Med
Date 2019 Mar 2
PMID 30821074
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

The Hippo pathway is an evolutionarily conserved regulator of organ size and tumorigenesis that negatively regulates cell growth and survival. Whether the Hippo pathway regulates cell metabolism is unknown. Here, we report that in the nucleus of hepatocytes, Yes-associated protein(YAP)-the terminal effector of the Hippo pathway-directly interacts with sterol regulatory element binding proteins (SREBP-1c and SREBP-2) on the promoters of the fatty acid synthase (FAS) and 30-hydroxylmethyl glutaryl coenzyme A reductase (HMGCR), thereby stimulating their transcription and promoting hepatocyte lipogenesis and cholesterol synthesis. In diet-induced diabetic mice, either Lats1 overexpression or YAP knockdown protects against hepatic steatosis and hyperlipidaemia through suppression of the interaction between YAP and SREBP-1c/SREBP-2. These results suggest that YAP is a nuclear co-factor of SREBPs and that the Hippo pathway negatively affects hepatocyte lipogenesis by inhibiting the function of YAP-SREBP complexes.

Citing Articles

Twelve Shugan Lidan Granules from traditional Chinese medicine can improve liver function in patients with postoperative hepatolithiasis by inhibiting the Hippo signaling pathway.

Li L, Niu X, Zhang W, Wang Z, Zhang S, Zhang Q Am J Transl Res. 2024; 16(11):7186-7199.

PMID: 39678602 PMC: 11645594. DOI: 10.62347/VXHU6738.


Hepatocyte-Specific Knockout Maintained the Liver Homeostasis of Lipid Metabolism in Mice.

Li C, Xue Y, Liu Y, Zheng K, Gao Y, Gong Y Diabetes Metab Syndr Obes. 2024; 17:3197-3214.

PMID: 39220798 PMC: 11365535. DOI: 10.2147/DMSO.S472778.


Adolescent exposure to a mixture of per- and polyfluoroalkyl substances (PFAS) depletes the ovarian reserve, increases ovarian fibrosis, and alters the Hippo pathway in adult female mice.

Clark K, George J, Davis J Toxicol Sci. 2024; 202(1):36-49.

PMID: 39141488 PMC: 11514835. DOI: 10.1093/toxsci/kfae103.


Interplay Between Fatty Acids, Stearoyl-Co-A Desaturase, Mechanistic Target of Rapamycin, and Yes-Associated Protein/Transcriptional Coactivator With PDZ-Binding Motif in Promoting Hepatocellular Carcinoma.

Benhammou J, Sinnett-Smith J, Pisegna J, Rozengurt E Gastro Hep Adv. 2024; 2(2):232-241.

PMID: 39132609 PMC: 11308718. DOI: 10.1016/j.gastha.2022.07.017.


Lipid metabolism dynamics in cancer stem cells: potential targets for cancers.

Du J, Qin H Front Pharmacol. 2024; 15:1367981.

PMID: 38994204 PMC: 11236562. DOI: 10.3389/fphar.2024.1367981.


References
1.
Surwit R, Seldin M, Kuhn C, Cochrane C, Feinglos M . Control of expression of insulin resistance and hyperglycemia by different genetic factors in diabetic C57BL/6J mice. Diabetes. 1991; 40(1):82-7. DOI: 10.2337/diab.40.1.82. View

2.
Shao D, Zhai P, Del Re D, Sciarretta S, Yabuta N, Nojima H . A functional interaction between Hippo-YAP signalling and FoxO1 mediates the oxidative stress response. Nat Commun. 2014; 5:3315. PMC: 3962829. DOI: 10.1038/ncomms4315. View

3.
Chen G, Liang G, Ou J, Goldstein J, Brown M . Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver. Proc Natl Acad Sci U S A. 2004; 101(31):11245-50. PMC: 509189. DOI: 10.1073/pnas.0404297101. View

4.
Stoeckman A, Towle H . The role of SREBP-1c in nutritional regulation of lipogenic enzyme gene expression. J Biol Chem. 2002; 277(30):27029-35. DOI: 10.1074/jbc.M202638200. View

5.
Horton J, Goldstein J, Brown M . SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest. 2002; 109(9):1125-31. PMC: 150968. DOI: 10.1172/JCI15593. View